Ligand
|
D1 nMa,b
|
D2 nMc
|
D3 nMc
|
D4 nMd
|
[3H]Clozapine
|
---|
SCH 23390
|
0.11
|
1,000
|
—
|
—
|
—
|
(+) Butaclamol
|
0.90
|
0.83
|
—
|
40
|
1,000
|
Ketanserin
|
190
|
>1,000
|
—
|
148
|
—
|
Spiperone
|
220
|
0.07
|
0.61
|
0.05
|
30
|
Apomorphine
|
210
|
24
|
20
|
4.1
|
50,000
|
Dopamine
|
2,500
|
474
|
25
|
28
|
500,000
|
Haloperidol
|
203
|
0.45
|
9.8
|
5.1
|
400
|
Bromocriptine
|
—
|
5.3
|
7.4
|
340
|
200
|
Domperidone
|
—
|
0.3
|
9.5
|
—
|
6,000
|
Thioridazine
|
—
|
3.3
|
7.8
|
12
|
30
|
Chlorpromazine
|
—
|
2.8
|
6.1
|
37
|
20
|
Raclopride
|
—
|
1.8
|
3.5
|
237
|
>10,000
|
Eticlopride
|
—
|
—
|
—
|
2.1
|
>10,000
|
Fluphenazine
|
—
|
—
|
—
|
46
|
20
|
Trifluoperazine
|
—
|
—
|
—
|
3
|
30
|
Clozapine
|
—
|
56
|
180
|
9
|
10
|
- All numbers represent Ki values from the literature as noted or [3H]clozapine to rat brain membranes. Values for drug potencies at [3H]clozapine binding sites are means of two to three determinations that varied less than 20%.
- aDeary et al. (16)
- bZhou et al. (17)
- cSokoloff et al. (18)
- dVan Tol et al. (9)